| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4a1a036688c917782503ecf3a3794e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-535 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16 |
| filingDate |
2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12bd66bf0ec5396604a1f794e6a130f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d3f657af2a891314590a5c29bbd4f25 |
| publicationDate |
2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130054948-A |
| titleOfInvention |
Methods of Obtaining Biologically Active Recombinant Human BCSC |
| abstract |
In a method for obtaining biologically active recombinant human G-CSF from inclusion bodies, solubilization and refolding processes can be carried out at room temperature and the purification step is provided by a method comprising reversed phase chromatography (RP), in particular RP-HPLC. do. The G-CSF preparation thus obtained is characterized by high purity and uniformity. |
| priorityDate |
2010-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |